Joey New York is divided into two divisions. One being “THE LABB”, Aesthetic Beauty Bar. The other is the Joey New York® cosmetics. There is a high degree of synergy between the Cosmetic line and the LABB services.

With the decades of skincare experience that the team at Joey have, it is only logical that they leverage their experience by employing a new concept in the injectables market, (Botox® and Fillers). It's a concept called The LABB (LabbAesthetic Beauty Bar). The LABB is focused on eliminating unwanted wrinkles by exclusively performing Botox® and filler injections, nothing else, no facials, no laser, just Botox® and fillers. This is a large segment of a 13-Billion-dollar market that has grown 6,400% since 1997. The concept is pretty simple. Excellent technicians, standardized training, multiple locations, consistent branding, incredibly low overhead and state of the art facilities with bulk buying purchasing power. With more people searching for a youthful look, Joey New York intends to lead them to it.

Investor SummaryJOEY NEW YORK (OTC – JOEY)

X Joey New York: 2 divisions – “THE LABB & Joey New York cosmetics

X High degree of synergy between cosmetic line and The LABB services

X THE LABB (Labb Aesthetic Beauty Bar)

X Decades of skin care experience

X Employing a new concept in the injectables market

X Focused on eliminating unwanted wrinkles by exclusively performing Botox and filler injections

X No facials, no lasers

X Excellent technicians, standardized training, multiple locations, consistent branding

X Low overhead in state of the art facilities with bulk buying power

X $13 Billion dollar market that has grown 6,400% since 1997

X With more people searching for a youthful look, Joey New York intends to lead them to it

FINANCIAL PROJECTIONS2017 2018 2019 2020 2021

Revenue $12,148,113 $40,183,936 $80,367,872 $118,951,808 $157,535,744

SG&A and COS $7,067,184 $22,830,400 $45,660,800 $67,456,200 $89,251,600

Net Profit $5,080,929 $17,353,536 $34,707,072 $51,495,608 $68,284,144

Outstanding Shares

27,862,019 32,000,000 37,000,000 42,000,000 49,000,000

Earnings per share

$0.18 $0.54 $0.94 $1.23 $1.39

X Deliver exceptional client experience

X Beauty enhancement through the use of cutting edge technology and aesthetic craftsmanship from convenient platform

X Poised to become foremost leader in

X Aesthetic service

X High quality injectables

X Most advanced technologies

X Tailored to individual patients

X Affordable pricing

X Exclusively injectables

X Streamline purchasing power

X Driving down costs

X Attractive option than visiting expensive cosmetic surgeons

THE LABB: THE MISSION

X South east Coastal Market represents 2nd largest injectable filler market in US (barely below California)

X 10 facilities identified to be opened in 2017 creating $5 million profit in 1st 12 monthsX Florida

X Boca Raton

X West Palm Beach

X Aventura

X Other select cities

X California and Las Vegas

X Additional 5 facilities in 2018X Total of 15 facilities yielding over $35 Million in profitX South Beach-Miami location open since 2016 – consistently booked with

wait listX Daytona Beach & Ft. Lauderdale location all cash flow positive

X Consistently growing customer base with 85% return clients

THE MARKET

2015 Highlights of Injectables

The needle reigns in 2015As a semi-invasive procedural option, injectables allow fans to minimize wrinkles and other tell-tale signs of aging on a temporary basis without going under

the knife

Botulinum Toxin(Botox, Dysport, Xeomin)

-up 18.9%

-up 6,448.9% since ASAPS began surveying injectabledata in 1997- Surpassed the 4 million procedures performed mark for the first time in 2015

Hyaluronic Acid(Juvaderm Ultra, Ultra Plus, Voluma, Perlane, Restylane and Belotero)-Up 26.6% in 2015 alone-Surpassed the 2 million procedures performed mark for the first time in 2015

Calcium Hydroxylapatite(Radiesse)

-Up 15.3% in 2015, since securing FDA approval for hand rejuvenation.-It is also used to smooth moderate to severe facial wrinkles and folds such as nasolabial folds.

Up18.9

%

INJECTABLES

Up26.6%

Up15.3%

Source: American Society for Aesthetic Plastic Surgery

Quick FactsX Americans spent more than $13.5 billion on combined surgical and non-surgical procedures in 2015

X A $1.5 billion increase in expenditures for combined surgical and non-surgical procedures from 2014-2015

X Non-surgical procedures up 22% with 10,879,909 performed

X Combined surgical & non-surgical up 20% compared to 2015

X A total of 12,792,377 procedures performed

X Injectables overall saw a 21% increase in 2015

X Belotero, Botox, Dysport, Juvederm Ultra, Juvederm Ultra Plus, Perlane, Poly-L-Lactic acid, Radiesse, Restylane, Voluma, Xeomin

X Injectables continue to be popular across the board, including men with 438,513 Botulinum Toxin and 159,052 Hyaluronic Acid injections performed in 2015

Source: American Society for Aesthetic Surgery

What sets up apart….VALUEX High quality aesthetic services at affordable price points

X High quality, evidence based aesthetic services are performed by a Nurse Practitioner who specializes in injectables

X By performing injectables exclusively and keeping a small product portfolio we can streamline purchasing power and drive down product cost

X Combining low operational overhead and optimizing our manufacturing rebates we can offer amazing pricing for top tier products

X Reduced price points makes The LABB extremely competitive in the market

X Will fill middle margin to optimize our customers VALUE and maximize the Return on Investment

X Low cost, high margin

X High Quality: Only FDA approved products purchased directly from the manufacturers

X The LABB only uses evidence based practices and on-label procedures

X The American Academy of Aesthetic Medicine has 3 levels of board certification for the injecting of Botox

X The LABB will use only Board Certified and specially trained providers who specialize in injectable treatments

X The LABB facilities are state of the art and licensed & registered with all compliance entities

Expertise & Ability to combine medical and

retail

Depth of knowledge of the markets &

direct to consumer

Original Model Scheme

Product Purchasing Power & Reduced

Pricing

Minimize Risk & Optimize Safety

THE LABB: VALUE ADDED

Source: American Society for Aesthetic Plastic Surgery

Nonsurgical ProcedureInjectables

2015 2014 1997 PercentChange

2015 vs 2014

PercentChange

2015vs 1997

2015 TotalsWith Phys

Ext.

Botulinum Toxin (including Botox, Sysport, Xeomin)

4,267,038 3,688,218 65,157 18.9% 6448.9% 6.706,339

Calcium Hydroxylapatite (Radiesse) 163,444 133,059 n/a 15.3% n/a 226,020

Hyaluronic Acid (incl. JuvedermUltra, Ultra Plus, Voluma, Perlane, Restylane, Belotero)

2,148,326 1,696,621 n/a 26.6% n/a 2,824,252

Poly-L-Latic Acid (Soulptra) 82,8116 79,313 n/a 4.4% n/a 102,356

Totals - Injectables 6,651,620

5,497,212

65,157

21% 6448% 8,857,968

Percent of Change in Select Procedures: 1997 – 2015 - Nonsurgical

n/a = Not available (was not collected in that year’s surveyHair transplantation, Polymethylacrylateand Cellulite treatment were excluded from the results due to an insufficient sample of responding physicians who perform those proceduresPercent Change totals are based on procedures for which data were collected in both years

Note that large percentage changes are common in casesWhere the total number of procedures is small

Nonsurgical Procedure Number of Procedures

2015 Rank within Category(non-surgical)

Injectables

Botulinum Toxin (including Botox, Sysport, Xeomin)

4,267,036 1

Calcium Hydroxylapatite (Radiesse) 153,444 11

Hyaluronic Acid (incl. Juvederm Ultra, Ultra Plus, Voluma, Perlane, Restylane, Belotero)

2,148,326 2

Poly-L-Latic Acid (Soulptra) 82,811 13

Totals - Injectables 6,651,620

NOTES• Botulinum Toxin, (Botox, Dysport and Xeomin) and Hyaluronic Acid, (Juvederm Ultra, Ultra Plus, Voluma, Perlane, Restylane

and Belotero) have maintained the #1 and #2 spots for most popular nonsurgical procedures for seven years running

2015 National Totals for Cosmetic Procedures - Nonsurgical

Source: American Society for Aesthetic Plastic Surgery

2015 Age Distribution for Cosmetic Procedures

Age

Age

Age

Age

Age

18 and under

19-34

35-50

51-64

65+

1.6%

15.9%

40.6%

31.2%

10.7%

Percent of TotalNonsurgical ProceduresBy Age

Total Population (rounded)=100%Source: American Society for Aesthetic Plastic Surgery

Headquarters Location

• Trump Tower 1

• 16001 Collins Avenue, Suite 3202

• Sunny Isles Beach, FL 33160

• www.joeynewyork.com

• Symbol: OTC JOEY

Key Management

• Joey Chancis, Founder/CEO

• Richard Roer, President

Current & Projected Performance

X The company expects to be profitable with accelerated growth in 2017 with expected revenue of more than $5M

X Future expectation of earnings beyond 2017, driven by increased consumer demand for healthy skin care products, is expected to be more than $9M on gross margins nearing 50% and net margins above 11%, on par with industry standards